Molecular Mechanisms in Reproductive Cancers
Submission Deadline: 30 Jun 2026
Guest Editor

Department of Experimental and Clinical Medicine, Faculty of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy
Interests: gynaecologic cancers; pregnancy complications; natural; synthetic, compounds; urogenital cancers; oxidative stress
Special Issue in IMR Press journals
Special Issue in Pathophysiology of Placenta
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit a manuscript to the Special Issue “Molecular Mechanisms in Reproductive Cancers”. Despite significant progress in tumor therapy over the past few decades, the development of chemoresistance and metastatic disease is still the most common cause of death in patients with reproductive cancer. These include cervical, ovarian, endometrial, vaginal, vulvar, breast, testicular, penile, and prostate cancers.
The development of new therapeutic approaches that can improve the diagnosis and treatment of these patients are therefore urgently required. A better understanding of the molecular changes in reproductive cancers should lead to the identification of useful molecular biomarkers that can accurately predict tumor outcome and the development of chemoresistance and metastasis.
For this Special Issue, we welcome original research articles and reviews, as well as communications, mini-reviews, systematic reviews and meta-analyses related to reproductive cancers.
We look forward to receiving your contributions.
Dr. Giovanni Tossetta
Guest Editor
Keywords
- cervical
- ovarian
- endometrial
- breast
- testicular
- prostate
- cancer
- reproductive cancers
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (2)
Long Non-Coding RNA RAB11B-AS1 Suppresses Cervical Cancer Progression by Upregulating RPL26 Expression
Front. Biosci. (Landmark Ed) 2026, 31(1), 47597; https://doi.org/10.31083/FBL47597
(This article belongs to the Special Issue Molecular Mechanisms in Reproductive Cancers)
Excavation of Molecular Subtypes of Cervical Cancer Based on DNA Methylation Patterns
Front. Biosci. (Landmark Ed) 2025, 30(9), 45025; https://doi.org/10.31083/FBL45025
(This article belongs to the Special Issue Molecular Mechanisms in Reproductive Cancers)
